Faron Appoints Interim Chief Medical Officer
Faron Pharmaceuticals Ltd. (“Faron” or the “Company”) Faron Appoints Dr. Birge Berns, MD as Interim Chief Medical Officer Dr. Marie-Louise Fjällskog, outgoing CMO, is proposed to continue key role in bexmarilimab’s development as a Board member Company announcement, September 21, 2023 TURKU, FINLAND / BOSTON, MA - Faron Pharmaceuticals Ltd. (AIM: FARN, First North: FARON), a clinical-stage biopharmaceutical company focused on tackling cancers via novel immunotherapies, today announces the appointment of Dr. Birge Berns, MD, as the Company’s